Keywords: Drug-induced liver injury; Hepatotoxicity; Gender differences; Drug property; Spontaneous adverse event reporting system; Liver events, and pharmacovigilance; DILI; drug-induced liver injury; DILIN; drug-induced liver injury network; HC; hepatocellular; C
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ALT; alanine aminotransferase; DILI; drug-induced liver injury; HBV; hepatitis B virus; HCV; hepatitis C virus; HDL; high-density lipoprotein; LDL; low-density lipoprotein; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OCA;
Keywords: AASLD; American Association for the Study of Liver Diseases; AIH; autoimmune hepatitis; AILDs; autoimmune liver diseases; BMD; bone mineral densitometry; CCA; cholangiocarcinoma; COIs; clinical outcome indicators; CRC; colorectal cancer; DAAs; direct acti
Keywords: acute coronary syndrome(s); definitions; myocardial infarction; ACL; angiographic core laboratory; ACS; acute coronary syndrome(s); CEC; clinical event committee; CK; creatine kinase; CRF; case report form; cTn; cardiac troponin; MI; myocardial infarction
Keywords: Antibiotic; Nonsteroidal Anti-inflammatory; Pain Reliever; Diagnostic; DILI; drug-induced liver injury; iDILI; idiosyncratic drug-induced liver injury; MH cells; monocyte-derived hepatocyte-like cells; RUCAM; Roussel Uclaf Causality Assessment Method; ULN
Keywords: Biliary; Drainage; Surgery; Temporary Stent; ACCS; Amsterdam Cholestatic Complaints Score; ALP; alkaline phosphatase; ASGE; American Society for Gastrointestinal Endoscopy; AST; aspartate aminotransferase; CI; confidence interval; DS; dominant stricture;
Keywords: AF; atrial fibrillation; ACT; activated clotting time; aPTT; activated partial thromboplastin time; b.i.d.; twice daily; dTT; diluted thrombin time; ECT; ecarin clotting time; FFP; fresh frozen plasma; FXa; factor X activated; INR; International Normalize
Keywords: Celiac Disease; Deamidated Gliadin; Gluten-Free Diet; Tissue Transglutaminase; AbCD; Antibody diagnostics in paediatric Coeliac Disease; BMI; body mass index; CD; celiac disease; GFD; gluten-free diet; IgG-DGL; IgG antibodies against deamidated gliadin; I
Keywords: Pulmonary arterial hypertension; Endothelin receptor antagonist; Prostacyclin; Nitric oxide; Dose titration; Specialty pharmacy; ERA; endothelin receptor antagonist; ET-1; endothelin 1; PAH; pulmonary arterial hypertension; PAWP; pulmonary artery wedge pr
Keywords: ALF; acute liver failure; ALT; alanine aminotransferase; APAP; acetaminophen; Gpat; glycerol-3-phosphate acyltransferase; LC-ESI-MS/MS; liquid chromatography with electrospray ionization and tandem triple quadrupole mass spectrometry; lyso-PA; lysophospha
Keywords: ATS; American thoracic society; BMI; body mass index; BSA; body surface area; CA; chronological-age; COPD; chronic obstructive pulmonary disease; ERS; European respiratory society; FEF200-1200; forced expiratory flow between 200 and 1200Â ml of the FVC; F
Keywords: 11BHSD; 11β-hydroxysteroid dehydrogenase; ACTH; adrenocorticotropic hormone; AE; adverse event; ALT; alanine aminotransferase; AUC; area under the curve; BMI; body mass index; CBG; cortisol binding globulin; CL/F; apparent total clearance of the drug fro
Keywords: EA; esophageal atresia; LGEA; long gap esophageal atresia; GPU; gastric pull-up; JI; jejunal interposition; TEF; tracheoesophageal fistula; LFT; lung function testing; UMCG; University Medical Center Groningen; UMCU; University Medical Center Utrecht; SD;
Keywords: AST; aspartate aminotransferase; ALT; alanine aminotransferase; CFTR; cystic fibrosis transmembrane conductance regulator; GGT; gamma-glutamyltranspeptidase; ULN; upper limit of normal; Cystic fibrosis liver disease; Newborn screening;
Keywords: Urea cycle disorders; Glycerol phenylbutyrate; Children; Infants; Ammonia; Glutamine; ARG1; arginase 1; ASL; argininosuccinate lyase; ASS; argininosuccinate synthetase; BMI; body mass index; BSA; body surface area; CDC; Centers for Disease Control and Pre
Keywords: complex PCI; robotic PCI; CK; creatine kinase; MA; manual assistance; MACE; major adverse cardiovascular event(s); MC; manual conversion; MI; myocardial infarction; M-PCI; manual percutaneous coronary intervention; PCI; percutaneous coronary intervention;
Keywords: IBD; inflammatory bowel disease; MS; multiple sclerosis; PML; progressive multifocal leukoencephalopathy; RBS; rectal bleeding subscore; S1P; sphingosine-1-phosphate; TNF; tumor necrosis factor; ULN; upper limit of normal; Sphingosine-1-phosphate; Inflamm
Keywords: Fontan circulation; congestive hepatopathy; hepatic fibrosis; congenital heart disease; adult congenital heart disease; AARCC; Alliance for Adult Research in Congenital Cardiology; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CT; comput
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; DILI; drug induced liver injury; AILI; amiodarone induced liver injury; ULN; upper limit of normal; CM; cardiomyopathy; Intravenous amiodarone; Parenteral amiodarone; Liver injury; Drug induc
Keywords: Database Analysis; Toxicity; Hepatotoxicity; Immune Response; Immunoglobulin; AIH; autoimmune hepatitis; Alk P; alkaline phosphatase; ALT; alanine aminotransferase; ANA; antinuclear antibody; AST; aspartate aminotransferase; DILI; drug-induced liver injur
Keywords: Gluten; Enteropathy; Children; Diagnosis; AUROC; area under the receiver operating characteristic curves; BMI; body mass index; CART; classification and regression analysis tree; DGP; deamidated gliaden peptide; DM; diabetes mellitus; EGD; esophagogastrod
Keywords: AbCD Study; Endoscopy; ELISA; Gluten; AbCD; Antibody Diagnostics in Paediatric Coeliac Disease trial; CI; confidence interval; EMA; endomysium antibody; ESPGHAN; European Society for Paediatric Gastroenterology, Hepatology, and Nutrition; GFD; gluten-free
Keywords: DILI; drug-induced liver injury; ALP; alkaline phosphatase; TB; total bilirubin; ULN; upper limit of normal; AST; aspartate aminotransferase; ALT; alanine aminotransferase; INR; international normalized ratio; R; ratio; HC; hepatocellular; Chol; cholestat
Keywords: AACE; American Association of Clinical Endocrinologists; ACC; American College of Cardiology; ACE; Africa Middle East Cardiovascular Epidemiological; AHA; American Heart Association; ASCVD; atherosclerotic cardiovascular disease; BMI; body mass index; CAD
Keywords: Pediatric pancreatitis; Prognostic markers; Prognostic model; Severe acute pancreatitis; Derivation cohort; Validation cohort; AP; acute pancreatitis; AUROC; Area Under the Receiver Operating Characteristic Curve; CHLA; Children's Hospital of Los Angeles;
Keywords: AE; adverse event; ALT; alanine aminotransferase; AST; aspartate aminotransferase; DRESS; drug reaction with eosinophilia and systematic symptoms; DSMB; data safety monitoring board; GGT; gamma-glutamyl transferase; GI; gastrointestinal; IL-2; interleukin
Keywords: Statin intolerance; Myalgias; Myopathy; PCSK9 inhibitors; ACC/AHA; American College of Cardiology/American Heart Association; ASCVD; Atherosclerotic cardiovascular disease; CoQ10; Coenzyme Q 10; CK; Creatine Kinase; FDA; Federal Drug Administration; HMG-C
Keywords: kidney; carcinoma; renal cell; neoplasm metastasis; nomograms; prognosis; CCF; Cleveland Clinic Foundation; C-index; concordance index; ECOG; Eastern Cooperative Oncology Group; IMDC; International Metastatic Renal Cell Carcinoma Database Consortium; IRTL
Keywords: Alanine aminotransferase; Alkaline phosphatase; Laboratory reference ranges; Liver chemistries; Pediatric clinical trials; ALT; alanine aminotransferase; ALP; alkaline phosphatase; AST; aspartate aminotransaminase; BMI; body mass index; NAFLD; nonalcoholi
Keywords: Acute pancreatitis; Biliary pancreatitis; Endoscopic retrograde cholangiopancreatography; Pancreatic stent; Outcome; Complication; ABP; acute biliary pancreatitis; AE; adeverse event; ALT; alanine aminotransferase; AP; acute pancreatitis; AST; aspartate a
Keywords: Cholestasis; Autoimmune Liver Disease; Prognosis; Predictive Factor; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; NRI; net reclassification improvement; PBC; primary biliary cirrhosis; UDCA; ursodeoxycholic acid
Keywords: Drug-induced Liver Injury; DILI; Hepatotoxicity; ALF; acute liver failure; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CLD; chronic liver disease; DI-ALF; drug-induced acute liver failure; DILI; drug-induced liver injury; DILIN; Drug-I
Keywords: Hepatitis B; Guidelines; Antiviral Therapy; Peginterferon alfa-2a; Entecavir; Tenofovir; Resistance; AFP; alpha-fetoprotein; ALT; alanine aminotransferase; anti-HBc; antibody to hepatitis B core antigen; anti-HBe; antibody to hepatitis B e antigen; anti-H
Keywords: Revised Atlanta Classification; Prospective validation; Early organ failure; Moderately severe acute pancreatitis; Infected necrosis; Clinical utility; AP; Acute pancreatitis; POF; persistent organ failure; ULN; upper limit of normal; CP; chronic pancreat
Keywords: AIH; autoimmunelike hepatitis; ALF; acute liver failure; ALT; alanine aminotransferase; CNS; central nervous system; DI-AIH; drug-induced autoimmunelike hepatitis; DILI; drug-induced liver injury; DILIN; Drug Induced Liver Injury Network; FDA; Food and Dr
Keywords: Autoimmune Liver Disease; Response To Treatment; Biomarker; New Therapies; CI; confidence interval; HR; hazard ratio; PBC; primary biliary cirrhosis; UDCA; ursodeoxycholic acid; ULN; upper limit of normal;
Keywords: Hepatotoxicity; Acute Liver Failure; Transplantation; Causality; ALT; alanine aminotransferase; ALP; alkaline phosphatase; AST; aspartate aminotransferase; CI; confidence interval; DILI; drug-induced liver injury; DILIN; Drug-Induced Liver Injury Network;
Keywords: Autoimmune Hepatitis; Cholestasis; Overlap; Atypical Phenotypes; AIH; autoimmune hepatitis; ALT; alanine aminotransferase; AMA; antimitochondrial antibody; AP; alkaline phosphatase; EASL; European Association for the Study of the Liver; ERC; endoscopic re
Keywords: 3-HB; 3-Hydroxybutyrate; ALP; alkaline phosphatase; ALT; alanine aminotransferase; APAP; acetaminophen; AST; aspartate aminotransferase; ATP; adenosine-5â²-triphosphate; CHOL; cholesterol; CTRL; control; CYP450; cytochrome P450; GGT; γ-glutamyl transfer
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
Keywords: AE; adverse event; AESI; adverse event of special interest; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CF; cystic fibrosis; CFQ-R; Cystic Fibrosis Questionnaire-Revised; CI; confidence interval; IV; intravenous; IVA; i
Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Keywords: Biomarker; Dysplasia; Endoscopy; Histology; FC; fecal calprotectin; IBD; inflammatory bowel disease; IBD-U; inflammatory bowel disease unclassified; IQR; interquartile range; MH; mucosal healing; OR; odds ratio; PSC; primary sclerosing cholangitis; PUCAI;
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
Keywords: Hepatotoxicity; Clinical Presentation; Herbal Signature; Re-challenge; AAS; anabolic androgenic steroids; ALF; acute liver failure; ALP; alkaline phosphatase; ALT; alanine transaminase; AST; aspartate aminotransferase; CAM; complementary and alternative m
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience
Keywords: IPF; idiopathic pulmonary fibrosis; AST; aspartate aminotransferase; ALT; alanine aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; ULN; upper limit of the normal range; BMI; body mass index; BSA; body surface area; FVC; forced vita
Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (â) mothers
Keywords: HBV; hepatitis B virus; HBsAg; hepatitis B virus surface antigen; HBeAg; hepatitis B virus e antigen; HepB; hepatitis B vaccine; HBIG; hepatitis B immunoglobulin; MTCT; mother-to-child transmission; anti-HBs; antibody to hepatitis B virus surface antigen;
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population
Keywords: TB; tuberculosis; ADR; adverse drug reaction; ATDH; Anti-TB drug-induced hepatotoxicity; DDI; drug-drug interaction; HIV; human immunodeficiency virus; NAT2; N-acetyltransferase 2; CYP; cytochrome P450; GST; glutathione S-transferase; ALT; alanine aminotr
Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy
Keywords: ALT; Alanine aminotransferase; CHB; Chronic hepatitis B; CM; Conditioned medium; CR; Complete response; HBeAg; Hepatitis B e antigen; HBsAg; Hepatitis B surface antigen; HBV; Hepatitis B virus; HC; Healthy control; ICS; Intracellular cytokines staining; I
Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials
Keywords: CI; confidence interval; NNT; number needed to treat; NSAID; non-steroidal anti-inflammatory drug; PEP; post-ERCP pancreatitis; RCT; randomized controlled trial; RR; risk ratio; ULN; upper limit of normal;
The “Scope” of Post-ERCP Pancreatitis
Keywords: BISAP; bedside index for severity in acute pancreatitis; CBD; common bile duct; CT; computed tomography; ERCP; endoscopic retrograde cholangiopancreatography; Fr; French; NNT; number needed to treat; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ra
Original scientific articleAntiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma
Keywords: ALT; alanine transaminase; AVT; antiviral therapy; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; OS; overall survival; RTDS; recurrence to death survival; TACE; transarterial chemoembolization; ULN; upper limit of normal;